Robert Porter

Viraspec AB provides point of care support in viral and bacterial detection. It offers products for detection of antibodies in blood and virus in saliva in patients with suspected COVID-19 infection. The company was founded in March 2020 and is headquartered in Lund, Sweden.

Thyrolytics AB operates as a diagnostics company. It develops diagnostic device for measuring thyroid hormone levels in the blood using nanotechnology and protein engineering. The company is headquartered in Lund, Sweden.

Rapivd Ltd. is a British company founded by Dr. Robert Porter in 2016 that specializes in converting rapid test prototypes into optimized, approved, manufacturable products. The private company is based in Sharnbrook, UK and is certified to ISO 13485 standards for medical devices. The company has built an exceptional industry reputation and have developed a proprietary device platform that has the potential to support the development of a new product category, namely quantitative rapid tests. Rapivd supports the needs of their clients in all areas of contract R&D and manufacturing. The company was founded in 2016 by Robert Andrew Porter, who has been the CEO since then.